Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest Content
Archive
For authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest Content
Archive
For authors
About
Podcasts
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
rheumatoid
Email alerts
rheumatoid
Sustained remission following the discontinuation of tofacitinib in patients with rheumatoid arthritis (XANADU study): an open-label randomised study
Satoshi
Kubo
,
Yusuke
Miyazaki
,
Koichi
Amano
,
Kiyoshi
Matsui
,
Hideto
Kameda
,
Yoshino
Inoue
,
Shingo
Nakayamada
,
Takehisa
Ogura
,
Yuko
Kaneko
,
Kunihiro
Yamaoka
,
Yoshiya
Tanaka
RMD Open
Apr 2023,
9
(2)
e003029;
DOI:
10.1136/rmdopen-2023-003029
Randomised study of PF-06410293, an adalimumab (ADL) biosimilar, compared with reference ADL for the treatment of active rheumatoid arthritis: results from weeks 26–52, including a treatment switch from reference ADL to PF-06410293
Roy M
Fleischmann
,
Daniel F
Alvarez
,
Amy E
Bock
,
Carol
Cronenberger
,
Ivana
Vranic
,
Wuyan
Zhang
,
Rieke
Alten
RMD Open
Apr 2021,
7
(2)
e001578;
DOI:
10.1136/rmdopen-2021-001578
Tofacitinib versus tocilizumab in the treatment of biological-naïve or previous biological-failure patients with methotrexate-refractory active rheumatoid arthritis
Shunsuke
Mori
,
Yukitomo
Urata
,
Tamami
Yoshitama
,
Yukitaka
Ueki
RMD Open
May 2021,
7
(2)
e001601;
DOI:
10.1136/rmdopen-2021-001601
Physical activity in patients with rheumatoid arthritis - an agile lifelong behaviour: a qualitative meta-synthesis
Emma
Swärdh
,
Christina
Opava
,
Nina
Brodin
RMD Open
May 2021,
7
(2)
e001635;
DOI:
10.1136/rmdopen-2021-001635
Short-term glucocorticoids reduce risk of chronic NSAID and analgesic use in early methotrexate-treated rheumatoid arthritis patients with favourable prognosis: subanalysis of the CareRA randomised controlled trial
Sofia
Pazmino
,
Annelies
Boonen
,
Diederik
De Cock
,
Veerle
Stouten
,
Johan
Joly
,
Delphine
Bertrand
,
René
Westhovens
,
Patrick
Verschueren
RMD Open
May 2021,
7
(2)
e001615;
DOI:
10.1136/rmdopen-2021-001615
Adverse events of special interest in clinical trials of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and psoriasis with 37 066 patient-years of tofacitinib exposure
Gerd R
Burmester
,
Peter
Nash
,
Bruce E
Sands
,
Kim
Papp
,
Lori
Stockert
,
Thomas V
Jones
,
Huaming
Tan
,
Ann
Madsen
,
Hernan
Valdez
,
Stanley B
Cohen
RMD Open
May 2021,
7
(2)
e001595;
DOI:
10.1136/rmdopen-2021-001595
Effectiveness of self-management interventions in inflammatory arthritis: a systematic review informing the 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis
Andréa
Marques
,
Eduardo
Santos
,
Elena
Nikiphorou
,
Ailsa
Bosworth
,
Loreto
Carmona
RMD Open
May 2021,
7
(2)
e001647;
DOI:
10.1136/rmdopen-2021-001647
Fluorescence optical imaging: ready for prime time?
Sarah
Ohrndorf
,
Anne-Marie
Glimm
,
Mads
Ammitzbøll-Danielsen
,
Mikkel
Ostergaard
,
Gerd R
Burmester
RMD Open
Jun 2021,
7
(2)
e001497;
DOI:
10.1136/rmdopen-2020-001497
Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effects
Josef S
Smolen
,
Roberto
Caporali
,
Thomas
Doerner
,
Bruno
Fautrel
,
Fabrizio
Benedetti
,
Burkhard
Pieper
,
Minjun
Jang
RMD Open
Jun 2021,
7
(2)
e001637;
DOI:
10.1136/rmdopen-2021-001637
Efficacy and safety of tofacitinib modified-release 11 mg once daily plus methotrexate in adult patients with rheumatoid arthritis: 24-week open-label phase results from a phase 3b/4 methotrexate withdrawal non-inferiority study (ORAL Shift)
Stanley B
Cohen
,
Janet
Pope
,
Boulos
Haraoui
,
Eduardo
Mysler
,
Annette
Diehl
,
Tatjana
Lukic
,
Shixue
Liu
,
Lori
Stockert
,
Rebecca
Germino
,
Sujatha
Menon
,
Harry
Shi
,
Edward C
Keystone
RMD Open
Jun 2021,
7
(2)
e001673;
DOI:
10.1136/rmdopen-2021-001673
Pages
1
2
3
4
5
6
7
8
next ›
last »
Special collections
Guidelines, Recommendations and Consensus Statements
Press releases
(1)